المؤلفون: Sallin, MA, Kauffman, KD, Riou, CR, Du Bruyn, E, Foreman, TW, Sakai, S, Hoft, SG, Myers, TG, Gardina, PJ, Sher, AF, Moore, R, Wilder-Kofie, T, Moore, IN, Sette, A, Lindestam Arlehamn, CS, Wilkinson, RJ, Barber, DL

المساهمون: Wellcome Trust

مصطلحات موضوعية: TH1, Science & Technology, T-CELL RESPONSES, INTERFERON-GAMMA, VACCINE, HUMANS, respiratory system, PROTECTIVE IMMUNITY, PHENOTYPE, Life Sciences & Biomedicine, Microbiology, DISEASE

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1032::f53e50dccb6bd36e2aaf1f3300dec372
http://hdl.handle.net/10044/1/62804

المؤلفون: Nelson CE; T lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Foreman TW; T lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Fukutani ER; Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Kauffman KD; T lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Sakai S; T lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Fleegle JD; Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Gomez F; Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Gould ST; T lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Le Nouën C; RNA Viruses Section, Laboratory of Infectious Disease, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Liu X; RNA Viruses Section, Laboratory of Infectious Disease, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Burdette TL; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Garza NL; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Lafont BAP; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Brooks K; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America., Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California, United States of America., Hickman HD; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Disease, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Johnson RF; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Oberman JP; Holy Cross Germantown Hospital, Affiliate of National Breathe Free Sinus and ENT Center, Frederick Breathe Free Sinus and ENT Center, Frederick, Maryland, United States of America., Quieroz ATL; Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil., Andrade BB; Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America., Via LE; Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.; Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Observatory, South Africa., Barber DL; T lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.

مؤلفون مشاركون: NIAID/DIR Tuberculosis Imaging Program

المصدر: PLoS pathogens [PLoS Pathog] 2024 Jul 01; Vol. 20 (7), pp. e1012339. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

مواضيع طبية MeSH: Macaca mulatta* , Interleukin-10*/immunology , Interleukin-10*/metabolism , COVID-19*/immunology , SARS-CoV-2*/immunology , Memory T Cells*/immunology , Memory T Cells*/metabolism , Immunologic Memory*/immunology, Animals ; Lung/immunology ; Lung/virology ; Lung/pathology ; Disease Models, Animal ; Interferon-gamma/metabolism ; Interferon-gamma/immunology ; T-Lymphocytes/immunology

المؤلفون: Mentzer AJ; Centre for Human Genetics, University of Oxford, Oxford, UK. alexander.mentzer@ndm.ox.ac.uk.; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK. alexander.mentzer@ndm.ox.ac.uk., Dilthey AT; Centre for Human Genetics, University of Oxford, Oxford, UK.; Institute of Medical Microbiology and Hospital Hygiene, University Hospital of Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA., Pollard M; Wellcome Sanger Institute, Cambridge, UK., Gurdasani D; Wellcome Sanger Institute, Cambridge, UK., Karakoc E; Wellcome Sanger Institute, Cambridge, UK., Carstensen T; Wellcome Sanger Institute, Cambridge, UK., Muhwezi A; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Cutland C; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Diarra A; Groupe de Recherche Action en Santé (GRAS) 06 BP 10248, Ouagadougou, Burkina Faso., da Silva Antunes R; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Paul S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Smits G; National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Wareing S; Microbiology Department, John Radcliffe Hospital, Oxford University NHS Foundation Trust, Oxford, UK., Kim H; Histogenetics, New York, USA., Pomilla C; Wellcome Sanger Institute, Cambridge, UK., Chong AY; Centre for Human Genetics, University of Oxford, Oxford, UK., Brandt DYC; Department of Integrative Biology, University of California at Berkeley, California, CA, USA., Nielsen R; Department of Integrative Biology, University of California at Berkeley, California, CA, USA., Neaves S; Avon Longitudinal Study of Parents and Children at University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Timpson N; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK., Crinklaw A; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Lindestam Arlehamn CS; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Rautanen A; Centre for Human Genetics, University of Oxford, Oxford, UK., Kizito D; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Parks T; Centre for Human Genetics, University of Oxford, Oxford, UK.; Department of Infectious Disease, Imperial College London, London, UK., Auckland K; Centre for Human Genetics, University of Oxford, Oxford, UK., Elliott KE; Centre for Human Genetics, University of Oxford, Oxford, UK., Mills T; Centre for Human Genetics, University of Oxford, Oxford, UK., Ewer K; The Jenner Institute, University of Oxford, Oxford, UK., Edwards N; The Jenner Institute, University of Oxford, Oxford, UK., Fatumo S; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; The Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine London, London, UK., Webb E; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine London, London, UK., Peacock S; Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Jeffery K; Microbiology Department, John Radcliffe Hospital, Oxford University NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., van der Klis FRM; National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Kaleebu P; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Vijayanand P; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Peters B; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, La Jolla, CA, USA., Sette A; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, La Jolla, CA, USA., Cereb N; Histogenetics, New York, USA., Sirima S; Groupe de Recherche Action en Santé (GRAS) 06 BP 10248, Ouagadougou, Burkina Faso., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Elliott AM; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine London, London, UK., McVean G; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK., Hill AVS; Centre for Human Genetics, University of Oxford, Oxford, UK.; The Jenner Institute, University of Oxford, Oxford, UK., Sandhu MS; Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK. m.sandhu@imperial.ac.uk.

المصدر: Nature medicine [Nat Med] 2024 May; Vol. 30 (5), pp. 1384-1394. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: HLA-DRB1 Chains*/genetics , HLA-DRB1 Chains*/immunology, Humans ; Infant ; Black People/genetics ; Hepatitis B Vaccines/immunology ; Quantitative Trait Loci ; Male ; Female ; Uganda ; Antibody Formation/genetics ; Antibody Formation/immunology ; Pertussis Vaccine/immunology ; Pertussis Vaccine/genetics ; Vaccination ; Whooping Cough/prevention & control ; Whooping Cough/immunology ; Whooping Cough/genetics

المؤلفون: Williams GP; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Yu ED; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Shapiro K; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Wang E; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Freuchet A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Frazier A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Lindestam Arlehamn CS; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA., Sette A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; University of California San Diego School of Medicine, La Jolla, San Diego, CA, USA., da Silva Antunes R; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA. Electronic address: rantunes@lji.org.

المصدر: Human immunology [Hum Immunol] 2024 May; Vol. 85 (3), pp. 110770. Date of Electronic Publication: 2024 Mar 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Country of Publication: United States NLM ID: 8010936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1166 (Electronic) Linking ISSN: 01988859 NLM ISO Abbreviation: Hum Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/immunology , COVID-19*/complications , SARS-CoV-2*/immunology , CD8-Positive T-Lymphocytes*/immunology , CD4-Positive T-Lymphocytes*/immunology , Post-Acute COVID-19 Syndrome*, Humans ; Male ; Middle Aged ; Female ; Adult ; Aged ; Autoimmunity/immunology ; Cytokines/metabolism ; Cytokines/immunology ; Autoantigens/immunology

المؤلفون: Marty PK; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Pathakumari B; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Cox TM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Van Keulen VP; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America.; Department of Immunology, Mayo Clinic, Rochester, MN, United States of America., Erskine CL; Department of Immunology, Mayo Clinic, Rochester, MN, United States of America., Shah M; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Vadiyala M; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Arias-Sanchez P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Karnakoti S; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Pennington KM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America., Theel ES; Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, United States of America., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States of America., Peikert T; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America.; Department of Immunology, Mayo Clinic, Rochester, MN, United States of America., Escalante P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America.

المصدر: PloS one [PLoS One] 2024 Apr 19; Vol. 19 (4), pp. e0301659. Date of Electronic Publication: 2024 Apr 19 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Mycobacterium Infections, Nontuberculous*/microbiology , Pneumonia*, Humans ; Pilot Projects ; Prospective Studies ; Leukocytes, Mononuclear ; Nontuberculous Mycobacteria

المؤلفون: Ogongo P; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States.; Department of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, Kenya., Tran A; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States., Marzan F; Drug Research Unit, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States., Gingrich D; Drug Research Unit, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States., Krone M; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States., Aweeka F; Drug Research Unit, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, United States., Hunt PW; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States., Ernst JD; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Apr 18; Vol. 15, pp. 1378040. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Bacterial*/immunology , HIV Infections*/immunology , HIV Infections*/virology , Interleukin-17*/metabolism , Interleukin-17*/immunology , Latent Tuberculosis*/immunology , Latent Tuberculosis*/microbiology , Mycobacterium tuberculosis*/immunology , Th17 Cells*/immunology , Th17 Cells*/metabolism, Adult ; Female ; Humans ; Male ; Middle Aged ; Immunophenotyping ; Kynurenine/metabolism ; Phenotype ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Tryptophan/metabolism

المؤلفون: Panda S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Kearns K; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Cheng C; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Lindestam Arlehamn CS; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA. Electronic address: cecilia@lji.org.

المصدر: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Apr; Vol. 141S, pp. 106983. Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis*/diagnosis , Tuberculosis*/prevention & control , Mycobacterium tuberculosis*/genetics, Humans ; Proteomics ; Antigens, Bacterial ; Interferon-gamma ; Immunity ; Epitopes

المؤلفون: Anidi IU; Critical Care Medicine and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Sakai S; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Brooks K; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fling SP; Cancer Immunotherapy Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Wagner MJ; Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California, USA., Knox KS; Department of Internal Medicine, College of Medicine Phoenix, University of Arizona Health Sciences, Phoenix, Arizona, USA., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Uldrick TS; Cancer Immunotherapy Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sharon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Barber DL; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2024 Mar 31; Vol. 11 (5), pp. ofae183. Date of Electronic Publication: 2024 Mar 31 (Print Publication: 2024).

نوع المنشور: Clinical Trial

بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

المؤلفون: Ogongo P; Division of Experimental Medicine, University of California, San Francisco, CA, USA.; Department of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, Kenya., Wassie L; Mycobacterial Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Tran A; Division of Experimental Medicine, University of California, San Francisco, CA, USA., Columbus D; Division of Experimental Medicine, University of California, San Francisco, CA, USA., Sharling L; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA., Ouma G; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Ouma SG; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Bobosha K; Mycobacterial Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Lindestam Arlehamn CS; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA., Gandhi NR; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA., Auld SC; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, USA., Rengarajan J; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Emory Vaccine Center, Emory University, Atlanta, GA, USA., Day CL; Emory Vaccine Center, Emory University, Atlanta, GA, USA.; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA., Altman JD; Emory Vaccine Center, Emory University, Atlanta, GA, USA., Blumberg HM; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA., Ernst JD; Division of Experimental Medicine, University of California, San Francisco, CA, USA.

مؤلفون مشاركون: TBRU ASTRa Study Group

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Ogongo P; Division of Experimental Medicine, University of California, San Francisco, CA, USA.; Department of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, Kenya., Tran A; Division of Experimental Medicine, University of California, San Francisco, CA, USA., Marzan F; Drug Research Unit, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA., Gingrich D; Drug Research Unit, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA., Krone M; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Aweeka F; Drug Research Unit, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA., Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, CA, USA., Hunt PW; Division of Experimental Medicine, University of California, San Francisco, CA, USA., Ernst JD; Division of Experimental Medicine, University of California, San Francisco, CA, USA.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE